Efficacy of Unstable Shoes for Instability and Lumbopelvic Pain
NCT ID: NCT03065270
Last Updated: 2017-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2011-09-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
40 % of women have postpartum lumbopelvic instability. In 17 % of cases the lumbopelvic pain is perpetuated.
Another alteration influenced by the gestational status and progress of labor is urinary incontinence (UI).
The mechanism developed by Masai Barefoot Technology (MBT) provides an unstable base. Some studies reviewed, indicate that this shoe increases muscle activity, contributes to the decrease of joint overload and thereby, decreases pain.
Objective To compare the efficacy of shoes with unstable sole MBT®, over the use of conventional sports shoes, in primiparous women with lumbopelvic postpartum pain.
Material and Methods Randomized clinical trial. 24 postpartum women from the Gynecology Service of the Hospital Universitario Madrid Chiron were included in the study.
The subjects were randomly divided into experimental and control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of the Unstable Shoes in Lower Limb Lymphedema.
NCT05996939
Effects of Unstable Shoes on Trunk Muscle Activity, Lumbar Spine Kinematics and Pain in Patients With Low Back Pain
NCT02606370
Effectiveness of Lumbopelvic Stabilization Exercises for Pregnancy-related Low Back Pain
NCT02606786
Evaluation of the Effect of Lumbar Belt on Spinal Mobility in Subjects With and Without Low Back Pain
NCT05600543
Impact of Postural Balance Changes on Low Back Pain During Pregnancy
NCT06713759
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A group
Use unstable shoes Masai Barefoot Technology (MBT)
Use of unstable shoes during 9 weeks, at least four hours per day.
B group
Use conventional sport shoes
Use of conventional sport shoes during 9 weeks, at least four hours per day.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use unstable shoes Masai Barefoot Technology (MBT)
Use of unstable shoes during 9 weeks, at least four hours per day.
Use conventional sport shoes
Use of conventional sport shoes during 9 weeks, at least four hours per day.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Postpartum, between 8-12 weeks after the date of delivery.
* With lumbopelvic pain and positive diagnostic tests of sacroiliac pain
* Women with ambulation ability.
Exclusion Criteria
* Be receiving another treatment for the alteration that concerns us, pharmacological or any other type of therapy.
* Neuromuscular alterations.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Europea de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raquel Díaz-Meco Conde
Principal Investigador
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raquel Diaz-Meco Conde, Doctor
Role: PRINCIPAL_INVESTIGATOR
Universidad Europea
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UEM-DOL-2011-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.